PURPOSE. Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for glaucoma. Since the introduction of new molecules in clinical routine, the current role of beta-blockers in glaucoma therapy has been rediscussed. In particular, concerns have been raised regarding their actual safety profile. METHODS. This review will focus on the latest advances on the efficacy and safety profiles of non-selective beta-blockers. CONCLUSIONS. The data provided will help to trace a more appropriate role for beta-blockers in glaucoma therapy.
Beta-adrenergic antagonists in the treatment of glaucoma / Gandolfi, Sa; Cimino, L. - In: EUROPEAN JOURNAL OF OPHTHALMOLOGY. - ISSN 1120-6721. - 11:2(2001), pp. S63-S66. [10.1177/112067210101102s08]
Beta-adrenergic antagonists in the treatment of glaucoma
Cimino L
2001
Abstract
PURPOSE. Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for glaucoma. Since the introduction of new molecules in clinical routine, the current role of beta-blockers in glaucoma therapy has been rediscussed. In particular, concerns have been raised regarding their actual safety profile. METHODS. This review will focus on the latest advances on the efficacy and safety profiles of non-selective beta-blockers. CONCLUSIONS. The data provided will help to trace a more appropriate role for beta-blockers in glaucoma therapy.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
